SPC441

Mirikisúmab

  • Status:
    Veitt
  • Application date:
    2.10.2023
  • Application published:
    15.11.2024
  • Grant published:
    15.7.2025
  • Max expiry date:
    29.5.2038
  • Medicine name:
    Omvoh
  • Medicine for children:
    No

Timeline

Today
2.10.2023Application
15.11.2024Publication
15.7.2025Registration
29.5.2038Expires

Marketing license

  • IS authorization number:
    EU/1/23/1736
  • Date:
    12.6.2023
  • Foreign authorization number:
    EU/1/23/1736
  • Date:
    26.5.2023

Owner

  • Name:
    Eli Lilly and Company
  • Address:
    Lilly Corporate Center, Indianapolis, IN 46285 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 18.07.2025

Upload documents